Apogee Therapeutics (APGE) Other Non-Current Assets (2023 - 2026)
Apogee Therapeutics (APGE) posted quarterly Other Non-Current Assets of $8.5 million for Q1 2026, up 16.04% year-over-year from $7.3 million in Q1 2025, and down 1.79% quarter-over-quarter from $8.7 million in Q4 2025.
Apogee Therapeutics (APGE) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported Other Non-Current Assets for 4 consecutive years, with $8.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 16.04% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $8.5 million (up 16.04% YoY), while the FY2025 annual figure was $8.7 million, up 1641.16% from the prior year.
- Other Non-Current Assets declined to $8.5 million in Q1 2026 per APGE's latest filing, from $8.7 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $8.9 million in Q2 2025 and bottomed at $401000.0 in Q4 2023.
- Historically, Other Non-Current Assets has averaged $4.4 million across 4 years, with a median of $3.9 million in 2024.
- Annual changes were most pronounced in 2025 — Other Non-Current Assets soared 1792.52% — and 2026, when it advanced 16.04%.
- Apogee Therapeutics' Other Non-Current Assets stood at $401000.0 in 2023, then rose by 24.19% to $498000.0 in 2024, then jumped by 1641.16% to $8.7 million in 2025, then dropped by 1.79% to $8.5 million in 2026.
- Business Quant data shows APGE's Other Non-Current Assets at $8.5 million in Q1 2026, $8.7 million in Q4 2025, and $8.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Apogee Therapeutics | 10.14 Bn | 9.16 Bn | - | 10.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.61 Mn |
| Mar 31, 2026 | 8.52 Mn |
| Dec 31, 2025 | 8.67 Mn |
| Sep 30, 2025 | 8.74 Mn |
| Jun 30, 2025 | 8.86 Mn |
| Mar 31, 2025 | 7.34 Mn |
| Dec 31, 2024 | 498,000.00 |
| Sep 30, 2024 | 514,000.00 |
| Jun 30, 2024 | 468,000.00 |
| Mar 31, 2024 | 401,000.00 |
| Dec 31, 2023 | 401,000.00 |